Bvf Inc Portfolio Holdings

Bvf Inc

  • $2.28 Billion
  • Q1 2025

Bvf Inc has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $2.28 Billion distributed in 51 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Moon Lake Immunotherapeutics with a value of $772M, Axsome Therapeutics, Inc. with a value of $197M, Revolution Medicines, Inc. with a value of $176M, Kymera Therapeutics, Inc. with a value of $141M, and Mirum Pharmaceuticals, Inc. with a value of $126M.

Examining the 13F form we can see an decrease of $397M in the current position value, from $2.67B to 2.28B.

Bvf Inc is based out at San Francisco, CA

Below you can find more details about Bvf Inc portfolio as well as his latest detailed transactions.

Portfolio value $2.28 Billion
Healthcare: $2.28 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.44B
$772 Million 33.91% of portfolio
19,751,284
Q4 2024 Reduced 9.19%
$4.51B
$197 Million 8.66% of portfolio
1,690,221
Q1 2025 Added 21.77%
$3.49B
$176 Million 7.74% of portfolio
4,982,384
Q1 2025 Added 19.16%
$1.61B
$141 Million 6.21% of portfolio
5,161,801
Q4 2023 Added 8.92%
$1.62B
$126 Million 5.54% of portfolio
2,796,513
Q4 2024 Reduced 9.08%
$2.26B
$125 Million 5.47% of portfolio
2,575,015
Q1 2025 Added 35.53%
$581M
$97.4 Million 4.28% of portfolio
8,827,712
Q1 2025 Reduced 15.12%
$286M
$59.5 Million 2.61% of portfolio
2,983,026
Q1 2025 Reduced 17.91%
$4.68B
$57.7 Million 2.54% of portfolio
1,913,385
Q1 2025 New
$377M
$51.2 Million 2.25% of portfolio
7,754,129
Q1 2025 Added 202.01%
$356M
$43.5 Million 1.91% of portfolio
5,750,683
Q2 2024 Added 79.89%
$140M
$37.1 Million 1.63% of portfolio
19,822,436
Q1 2025 Added 1.54%
$392M
$36.7 Million 1.61% of portfolio
3,944,194
Q4 2024 Reduced 15.38%
$1.89B
$36.5 Million 1.61% of portfolio
1,454,422
Q1 2025 Reduced 7.33%
$157M
$35 Million 1.54% of portfolio
3,466,000
Q2 2024 New
$261M
$31.6 Million 1.39% of portfolio
6,904,050
Q4 2024 Added 962.16%
$185M
$26.3 Million 1.15% of portfolio
5,660,132
Q1 2025 Added 104.75%
$43.3M
$21.3 Million 0.94% of portfolio
6,293,282
Q2 2024 Added 45.45%
$211M
$19.9 Million 0.88% of portfolio
5,295,893
Q1 2025 Reduced 7.35%
$172M
$19.4 Million 0.85% of portfolio
5,302,000
Q2 2024 New
$305M
$18.4 Million 0.81% of portfolio
3,075,000
Q1 2025 Added 32.26%
$112M
$14.7 Million 0.65% of portfolio
4,561,289
Q1 2025 Added 70.79%
$72.7M
$13.8 Million 0.61% of portfolio
8,748,629
Q3 2022 Added 136.54%
$95.2M
$13.5 Million 0.59% of portfolio
7,000,000
Q4 2023 New
$36.5M
$11.3 Million 0.5% of portfolio
9,237,556
Q4 2024 New
$55.4M
$10.2 Million 0.45% of portfolio
10,333,600
Q4 2023 Added 24.62%
$27.2M
$9.7 Million 0.43% of portfolio
8,902,972
Q1 2024 New
$209M
$8.23 Million 0.36% of portfolio
2,372,933
Q4 2024 Reduced 45.65%
$223M
$7.14 Million 0.31% of portfolio
4,013,633
Q1 2025 Added 121.3%
$25.9M
$6.75 Million 0.3% of portfolio
4,889,474
Q1 2025 Added 63.56%
$128M
$5.25 Million 0.23% of portfolio
1,353,968
Q4 2024 Added 205.48%
$41.7M
$5.13 Million 0.23% of portfolio
4,006,564
Q4 2024 Reduced 15.99%
$28M
$3.81 Million 0.17% of portfolio
16,552,417
Q1 2024 Added 93.54%
$142M
$3.35 Million 0.15% of portfolio
5,228,461
Q2 2024 Reduced 20.73%
$139M
$2.02 Million 0.09% of portfolio
686,040
Q1 2022 Added 25.99%
$12.1M
$2 Million 0.09% of portfolio
9,544,262
Q4 2020 Added 31.75%
$20.4M
$1.19 Million 0.05% of portfolio
3,853,818
Q1 2024 Reduced 43.75%
Engene Holdings Inc
-
$0 0.0% of portfolio
-
Q4 2023 New
Forte Biosciences Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 398.22%
-
$0 0.0% of portfolio
-
Q1 2025 New
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 7.21%
Verastem Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 24.64%
Sab Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Nls Pharmaceutics LTD
-
$0 0.0% of portfolio
-
Q3 2024 New
Tenax Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 20.88%
Septerna Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 79.29%
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 15.39%
Palvella Therapeutics Inc Ne
-
$0 0.0% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 51
  • Current Value $2.28 Billion
  • Prior Value $2.67 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 2 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email